Align Technology Inc.

5 hours ago · seekingalpha.com

Align Technology remains the global leader in clear aligners but faces intensifying competition and declining pricing power, especially in North America. ALGN's US market is saturated, with falling shipments, utilization, and revenue per case; international growth is now the primary driver. Gross margins and brand strength are under pressure, with competitors gaining share through lower costs and improved aesthetics.

3 days ago · seekingalpha.com

Align Technology faces new catalysts, developments, and litigation progress that shift the investment landscape. Market sentiment currently appears to emphasize the risks associated with ALGN over potential opportunities. I now favor an intrinsic valuation approach based on future cash flows rather than relying solely on multiples or peer averages.

4 days ago · zacks.com

Align Technology's Q3 earnings and revenues beat estimates on higher aligner shipments, but a lowered 2026 sales outlook weighs on shares.

4 days ago · marketbeat.com

Align Technology NASDAQ: ALGN reported third-quarter 2026 revenue of $1.015 billion, up 1.9% from a year earlier, as higher clear aligner volumes and international growth helped offset continued pressure in discretionary dental spending and capital-equipment purchasing.

4 days ago · seekingalpha.com

Align Technology, Inc. (ALGN) Q3 2026 Earnings Call Transcript

5 days ago · zacks.com

The headline numbers for Align Technology (ALGN) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

5 days ago · zacks.com

Align Technology (ALGN) came out with quarterly earnings of $2.8 per share, beating the Zacks Consensus Estimate of $2.76 per share. This compares to earnings of $2.61 per share a year ago.

5 days ago · businesswire.com

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the third quarter ("Q3'26"). Commenting on Align's Q3'26 results, Align Technology President and CEO Joe Hogan said, “We delivered solid third-quarter results, with.

6 days ago · zacks.com

Investors need to pay close attention to ALGN stock based on the movements in the options market lately.

8 days ago · businesswire.com

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced a new $1 million, five-year commitment to the American Association of Orthodontists (AAO) Foundation building on the Company's most recent $1 million pledge made in 2021. The commitment.